社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Acurx Pharmaceuticals, LLC*(ACXP)
盘后
4.90
0.02
+0.41%
19:58 EDT
4.88
+0.07
+1.46%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
getimer
·
2025-10-08
$Acurx Pharmaceuticals, LLC*(ACXP)$
蓄能差不多了，可以冲了
$Acurx Pharmaceuticals, LLC*(ACXP)$ 蓄能差不多了，可以冲了
回复
评论
点赞
1
编组 21备份 2
分享
举报
低端小乐乐
·
2025-06-18
$休斯敦能源(HUSA)$
这周还没过完，战果已够吹三年。17个捡钱机会，11次躺赚50%+。附赠前两周收益图，懂的都懂。订阅追踪别掉队，吃肉喝汤不迷路。6月16日战绩：
$Battalion Oil Corp(BATL)$
132%飞天，
$SRM Entertainment, Inc.(SRM)$
113%窜云，
$斯塔克工业(STAK)$
61%稳健，
$SAVERONE 2014 LTD(SVRE)$
47%小跑，
$AIRO Group Holdings(AIRO)$
26%踱步，
$Oceanpal Inc(OP)$
16%龟速，
$Sonim Technologies Inc(SONM)$
15%蠕动。6月17日狂欢：
$休斯敦能源(HUSA)$
96%暴走，
$Salarius Pharmaceuti
$休斯敦能源(HUSA)$ 这周还没过完，战果已够吹三年。17个捡钱机会，11次躺赚50%+。附赠前两周收益图，懂的都懂。订阅追踪别掉队，吃肉喝汤不迷路。...
精彩
一档的风扇:
您好，怎么跟进追踪您的操作？
回复
4
点赞
5
编组 21备份 2
分享
举报
zeroxu666
·
2025-06-17
$Acurx Pharmaceuticals, LLC*(ACXP)$
发表二期实验数据，有94%的效果，准备进一步试验，并发表到柳叶刀
$Acurx Pharmaceuticals, LLC*(ACXP)$ 发表二期实验数据，有94%的效果，准备进一步试验，并发表到柳叶刀
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
Acurx Pharmaceuticals, LLC*
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.acurxpharma.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Acurx Pharmaceuticals, Inc.于2017年7月在特拉华州注册成立，于2018年2月开始运营。该公司是一家后期生物制药公司，专注于开发用于难治疗细菌感染的新型小分子抗生素，用于治疗被世界卫生组织列为优先病原体的细菌引起的感染（“WHO”），美国疾病控制与预防中心（“CDC”）和美国食品和药物管理局（“FDA”）。优先病原体是那些需要新抗生素来解决由WHO、CDC和FDA确定的全球抗微生物药物耐药性（“AMR”）危机的病原体。
03-12
年度报告
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
03-12
员工持股计划
Form S-8 - Securities to be offered to employees in employee benefit plans
Form S-8 - Securities to be offered to employees in employee benefit plans
03-09
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-02
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-11-12
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-21
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-09-22
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-09-19
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-08-11
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-07-31
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-07-22
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2025-07-17
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-07-15
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-06-20
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-05-28
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
分时
5日
日
周
月
数据加载中...
最高
5.68
今开
5.02
量比
0.16
最低
4.76
昨收
4.81
换手率
212.08%
热议股票
{"pagemeta":{"title":"Acurx Pharmaceuticals, LLC*(ACXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acurx Pharmaceuticals, LLC*(ACXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acurx Pharmaceuticals, LLC*,ACXP,Acurx Pharmaceuticals, LLC*股票,Acurx Pharmaceuticals, LLC*股票老虎,Acurx Pharmaceuticals, LLC*股票老虎国际,Acurx Pharmaceuticals, LLC*行情,Acurx Pharmaceuticals, LLC*股票行情,Acurx Pharmaceuticals, LLC*股价,Acurx Pharmaceuticals, LLC*股市,Acurx Pharmaceuticals, LLC*股票价格,Acurx Pharmaceuticals, LLC*股票交易,Acurx Pharmaceuticals, LLC*股票购买,Acurx Pharmaceuticals, LLC*股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acurx Pharmaceuticals, LLC*(ACXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acurx Pharmaceuticals, LLC*(ACXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"ACXP","data":{"stockData":{"symbol":"ACXP","market":"US","secType":"STK","nameCN":"Acurx Pharmaceuticals, LLC*","latestPrice":4.88,"timestamp":1773777600000,"preClose":4.81,"halted":0,"volume":5128307,"hourTrading":{"tag":"盘后","latestPrice":4.9,"preClose":4.88,"latestTime":"19:58 EDT","volume":52770,"amount":260417.0275,"timestamp":1773791925968,"change":0.02,"changeRate":0.004098,"amplitude":0.050758},"delay":0,"changeRate":0.014553014553014613,"floatShares":2418100,"shares":2855025,"eps":-5.32,"marketStatus":"已收盘","change":0.07,"latestTime":"03-17 16:00:00 EDT","open":5.02,"high":5.68,"low":4.76,"amount":26154753.912839897,"amplitude":0.191268,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.32,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773820800000},"marketStatusCode":5,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":4.81,"preHourTrading":{"tag":"盘前","latestPrice":5.02,"preClose":4.81,"latestTime":"09:29 EDT","volume":1072070,"amount":6125910.89872,"timestamp":1773754198728,"change":0.21,"changeRate":0.043659,"amplitude":0.338877},"postHourTrading":{"tag":"盘后","latestPrice":4.9,"preClose":4.88,"latestTime":"19:58 EDT","volume":52770,"amount":260417.0275,"timestamp":1773791925968,"change":0.02,"changeRate":0.004098,"amplitude":0.050758},"volumeRatio":0.1568,"impliedVol":1.1448,"impliedVolPercentile":0.6598},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.487009673060688","cardData":[{"tweetId":"487009673060688","author":{"authorId":"3535925794992626","idStr":"3535925794992626","name":"getimer","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":7,"crmLevelSwitch":1,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.09","exceedPercentage":"60.08%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACXP\">$Acurx Pharmaceuticals, LLC*(ACXP)$ </a> 蓄能差不多了，可以冲了","plainDigest":"$Acurx Pharmaceuticals, LLC*(ACXP)$ 蓄能差不多了，可以冲了","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1759927547148,"gmtModify":1759928463007,"symbols":["ACXP"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1077,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/487009673060688","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":54,"displayRows":4,"foldSize":0,"authorId":"3535925794992626"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.447573411275000","cardData":[{"tweetId":"447573411275000","author":{"authorId":"10000000000010463","idStr":"10000000000010463","name":"低端小乐乐","avatar":"https://static.tigerbbs.com/7e02002a4ff0970395fc8264888e847d","userType":8,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":68,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/HUSA\">$休斯敦能源(HUSA)$ </a>这周还没过完，战果已够吹三年。17个捡钱机会，11次躺赚50%+。附赠前两周收益图，懂的都懂。订阅追踪别掉队，吃肉喝汤不迷路。6月16日战绩：<a href=\"https://laohu8.com/S/BATL\">$Battalion Oil Corp(BATL)$ </a> 132%飞天，<a href=\"https://laohu8.com/S/SRM\">$SRM Entertainment, Inc.(SRM)$ </a> 113%窜云，<a href=\"https://laohu8.com/S/STAK\">$斯塔克工业(STAK)$ </a> 61%稳健，<a href=\"https://laohu8.com/S/SVRE\">$SAVERONE 2014 LTD(SVRE)$ </a> 47%小跑，<a href=\"https://laohu8.com/S/AIRO\">$AIRO Group Holdings(AIRO)$ </a> 26%踱步，<a href=\"https://laohu8.com/S/OP\">$Oceanpal Inc(OP)$ </a> 16%龟速，<a href=\"https://laohu8.com/S/SONM\">$Sonim Technologies Inc(SONM)$ </a> 15%蠕动。6月17日狂欢：<a href=\"https://laohu8.com/S/HUSA\">$休斯敦能源(HUSA)$ </a> 96%暴走，<a href=\"https://laohu8.com/S/SLRX\">$Salarius Pharmaceuti</a>","plainDigest":"$休斯敦能源(HUSA)$ 这周还没过完，战果已够吹三年。17个捡钱机会，11次躺赚50%+。附赠前两周收益图，懂的都懂。订阅追踪别掉队，吃肉喝汤不迷路。6月16日战绩：$Battalion Oil Corp(BATL)$ 132%飞天，$SRM Entertainment, Inc.(SRM)$ 113%窜云，$斯塔克工业(STAK)$ 61%稳健，$SAVERONE 2014 LTD(SVRE)$ 47%小跑，$AIRO Group Holdings(AIRO)$ 26%踱步，$Oceanpal Inc(OP)$ 16%龟速，$Sonim Technologies Inc(SONM)$ 15%蠕动。6月17日狂欢：$休斯敦能源(HUSA)$ 96%暴走，$Salarius Pharmaceuti","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1750261315000,"gmtModify":1750278612755,"symbols":["OP","CERO","RYDE","PCSA","ACXP","BATL","RELI","STAK","SRM","SVRE","HUSA","SLRX","APVO","PTLE","AIRO","SONM","LSE"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/3f616b9d69bcecdba4dc413df647eac1","width":"809","height":"629"}],"repostCount":2,"viewCount":11022,"likeCount":5,"liked":false,"collected":false,"commentCount":4,"hotComments":[{"id":"447843810324752","author":{"authorId":"3546635580545256","idStr":"3546635580545256","name":"一档的风扇","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"fanSize":0,"starInvestorFlag":false},"content":"您好，怎么跟进追踪您的操作？","plainContent":"您好，怎么跟进追踪您的操作？","likeCount":0,"commentType":"valid","coins":0},{"id":"455062229455200","author":{"authorId":"4184319806668240","idStr":"4184319806668240","name":"鹏程夜色","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":4,"crmLevelSwitch":0,"fanSize":3,"starInvestorFlag":false},"content":"实力不俗。。。。多交流","plainContent":"实力不俗。。。。多交流","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/447573411275000","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":753,"displayRows":4,"foldSize":0,"authorId":"10000000000010463"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.447034755469696","cardData":[{"tweetId":"447034755469696","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.51%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":69,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACXP\">$Acurx Pharmaceuticals, LLC*(ACXP)$</a> 发表二期实验数据，有94%的效果，准备进一步试验，并发表到柳叶刀","plainDigest":"$Acurx Pharmaceuticals, LLC*(ACXP)$ 发表二期实验数据，有94%的效果，准备进一步试验，并发表到柳叶刀","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1750160670985,"gmtModify":1750165499178,"symbols":["ACXP"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":913,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/447034755469696","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":91,"displayRows":4,"foldSize":0,"authorId":"3544572238091832"}],"position":0}],"size":3},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"20833368","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465926027052-ACXP","pdf_url":"","pub_time":1773288000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"ACXP","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/0001104659-26-027052-index.htm","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k.htm","primary":true,"translateUrl":"","linkName":"acxp-20251231x10k.htm","type":"10-K","id":"NTFILEEVhoB6rne48nGNgZ","market":"us","size":2423629},{"description":"EX-4.11","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231xex4d11.htm","primary":false,"translateUrl":"","linkName":"acxp-20251231xex4d11.htm","type":"EX-4.11","id":"NTFILE4jWD5Fji2L4HvBai","market":"us","size":33153},{"description":"EX-21.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231xex21d1.htm","primary":false,"translateUrl":"","linkName":"acxp-20251231xex21d1.htm","type":"EX-21.1","id":"NTFILE7iBt8ZXuNBmVpDAW","market":"us","size":1241},{"description":"EX-23.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231xex23d1.htm","primary":false,"translateUrl":"","linkName":"acxp-20251231xex23d1.htm","type":"EX-23.1","id":"NTFILE8J6GRncxvSUecaMi","market":"us","size":4091},{"description":"EX-31.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231xex31d1.htm","primary":false,"translateUrl":"","linkName":"acxp-20251231xex31d1.htm","type":"EX-31.1","id":"NTFILEACFPBG6UVBeeVDPT","market":"us","size":10646},{"description":"EX-31.2","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231xex31d2.htm","primary":false,"translateUrl":"","linkName":"acxp-20251231xex31d2.htm","type":"EX-31.2","id":"NTFILE3RrnSj4EoqBBL7qB","market":"us","size":10581},{"description":"EX-32.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231xex32d1.htm","primary":false,"translateUrl":"","linkName":"acxp-20251231xex32d1.htm","type":"EX-32.1","id":"NTFILEFoVwB28G6vFDbWhx","market":"us","size":4600},{"description":"EX-32.2","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231xex32d2.htm","primary":false,"translateUrl":"","linkName":"acxp-20251231xex32d2.htm","type":"EX-32.2","id":"NTFILEBQrDG6iuwsVfBa4e","market":"us","size":4645},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k002.jpg","primary":false,"translateUrl":"","linkName":"acxp-20251231x10k002.jpg","type":"GRAPHIC","id":"NTFILEVsnSHQn4aPCP1xN9","market":"us","size":40256},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k003.jpg","primary":false,"translateUrl":"","linkName":"acxp-20251231x10k003.jpg","type":"GRAPHIC","id":"NTFILE6GEUVoFDCWeGFCbG","market":"us","size":15929},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k004.jpg","primary":false,"translateUrl":"","linkName":"acxp-20251231x10k004.jpg","type":"GRAPHIC","id":"NTFILEB4bVMxJB1vfGnVQb","market":"us","size":83834},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k006.jpg","primary":false,"translateUrl":"","linkName":"acxp-20251231x10k006.jpg","type":"GRAPHIC","id":"NTFILEh6MAuiX5R2TyUn2f","market":"us","size":22880},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k007.jpg","primary":false,"translateUrl":"","linkName":"acxp-20251231x10k007.jpg","type":"GRAPHIC","id":"NTFILEHoAvfFj9GJuLLPeP","market":"us","size":17202},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k008.jpg","primary":false,"translateUrl":"","linkName":"acxp-20251231x10k008.jpg","type":"GRAPHIC","id":"NTFILE6asHDugYg95N9UJk","market":"us","size":7363},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k009.jpg","primary":false,"translateUrl":"","linkName":"acxp-20251231x10k009.jpg","type":"GRAPHIC","id":"NTFILE7zWXYxcjiMZ8Jz2E","market":"us","size":32289},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k011.jpg","primary":false,"translateUrl":"","linkName":"acxp-20251231x10k011.jpg","type":"GRAPHIC","id":"NTFILE6w8yjgrZYxhxjovw","market":"us","size":63354},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k012.jpg","primary":false,"translateUrl":"","linkName":"acxp-20251231x10k012.jpg","type":"GRAPHIC","id":"NTFILE4BkQjvp8SeqPaDWu","market":"us","size":92134},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k013.jpg","primary":false,"translateUrl":"","linkName":"acxp-20251231x10k013.jpg","type":"GRAPHIC","id":"NTFILEJAjonqKUnRJFu3RW","market":"us","size":121972},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k014.jpg","primary":false,"translateUrl":"","linkName":"acxp-20251231x10k014.jpg","type":"GRAPHIC","id":"NTFILE45fvURu9Z3xBopbk","market":"us","size":49687},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k015.jpg","primary":false,"translateUrl":"","linkName":"acxp-20251231x10k015.jpg","type":"GRAPHIC","id":"NTFILE6XGxAbuUEiQwwYY2","market":"us","size":23100}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2026-03-12 12:00","pubTimestamp":1773288000,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20833316","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465926027069-ACXP","pdf_url":"","pub_time":1773288000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"ACXP","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027069/0001104659-26-027069-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM S-8","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027069/tm267891d1_s8.htm","primary":true,"translateUrl":"","linkName":"tm267891d1_s8.htm","type":"S-8","id":"NTFILE9ddAdQ4KSckroae2","market":"us","size":34400},{"description":"EXHIBIT 5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027069/tm267891d1_ex5-1.htm","primary":false,"translateUrl":"","linkName":"tm267891d1_ex5-1.htm","type":"EX-5.1","id":"NTFILEDCYfhxPECboP2nc1","market":"us","size":9871},{"description":"EXHIBIT 23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027069/tm267891d1_ex23-1.htm","primary":false,"translateUrl":"","linkName":"tm267891d1_ex23-1.htm","type":"EX-23.1","id":"NTFILE3DA7J5dTeA6wZyNK","market":"us","size":2240},{"description":"EX-FILING FEES","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027069/tm267891d1_ex-filingfees.htm","primary":false,"translateUrl":"","linkName":"tm267891d1_ex-filingfees.htm","type":"EX-FILING FEES","id":"NTFILECHBEUyzM3w7PZ5EH","market":"us","size":16231},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027069/tm267891d1_ex5-1img001.jpg","primary":false,"translateUrl":"","linkName":"tm267891d1_ex5-1img001.jpg","type":"GRAPHIC","id":"NTFILE5Jdd2f8xgHqLJBVA","market":"us","size":3370},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926027069/tm267891d1_ex5-1img002.jpg","primary":false,"translateUrl":"","linkName":"tm267891d1_ex5-1img002.jpg","type":"GRAPHIC","id":"NTFILE7jchxm8w4yjxBiNA","market":"us","size":1770}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2026-03-12 12:00","pubTimestamp":1773288000,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20813553","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465926025003-ACXP","pdf_url":"","pub_time":1773028800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ACXP","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926025003/0001104659-26-025003-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926025003/tm268319d1_ex99-1.htm","primary":true,"translateUrl":"","linkName":"tm268319d1_ex99-1.htm","type":"EX-99.1","id":"NTFILE2WwdvrJs57z58yKo","market":"us","size":34191},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926025003/tm268319d1_8k.htm","primary":false,"translateUrl":"","linkName":"tm268319d1_8k.htm","type":"8-K","id":"NTFILE7YWmDCcqRtrGRLby","market":"us","size":34767}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-03-09 12:00","pubTimestamp":1773028800,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20689340","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465926009266-ACXP","pdf_url":"","pub_time":1770008400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"ACXP","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926009266/0001104659-26-009266-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926009266/tm264593-1_s1.htm","primary":true,"translateUrl":"","linkName":"tm264593-1_s1.htm","type":"S-1","id":"NTFILE2cWdFLd8QPccsz6c","market":"us","size":505451},{"description":"EXHIBIT 5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926009266/tm264593d2_ex5-1.htm","primary":false,"translateUrl":"","linkName":"tm264593d2_ex5-1.htm","type":"EX-5.1","id":"NTFILE4SdPowGraYAR5XeP","market":"us","size":8614},{"description":"EXHIBIT 23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926009266/tm264593d2_ex23-1.htm","primary":false,"translateUrl":"","linkName":"tm264593d2_ex23-1.htm","type":"EX-23.1","id":"NTFILEAEYRoVz68s2a8Nou","market":"us","size":2598},{"description":"EX-FILING FEES","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926009266/tm264593d2_ex-filingfees.htm","primary":false,"translateUrl":"","linkName":"tm264593d2_ex-filingfees.htm","type":"EX-FILING FEES","id":"NTFILEB9UHzni7jaNJRVi1","market":"us","size":25783},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926009266/tm264593d2_ex5-1img01.jpg","primary":false,"translateUrl":"","linkName":"tm264593d2_ex5-1img01.jpg","type":"GRAPHIC","id":"NTFILEAgKusFZ2cNxgtkDo","market":"us","size":4591}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2026-02-02 13:00","pubTimestamp":1770008400,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20397779","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925109698-ACXP","pdf_url":"","pub_time":1762923600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"ACXP","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925109698/0001104659-25-109698-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925109698/acxp-20250930x10q.htm","primary":true,"translateUrl":"","linkName":"acxp-20250930x10q.htm","type":"10-Q","id":"NTFILEFQQXbs6M5bhgdVUz","market":"us","size":1734294},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925109698/acxp-20250930xex31d1.htm","primary":false,"translateUrl":"","linkName":"acxp-20250930xex31d1.htm","type":"EX-31.1","id":"NTFILE7m18ZgUGwRvS29VD","market":"us","size":12539},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925109698/acxp-20250930xex31d2.htm","primary":false,"translateUrl":"","linkName":"acxp-20250930xex31d2.htm","type":"EX-31.2","id":"NTFILE2gA8D4DAYKBxZsbY","market":"us","size":12544},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925109698/acxp-20250930xex32d1.htm","primary":false,"translateUrl":"","linkName":"acxp-20250930xex32d1.htm","type":"EX-32.1","id":"NTFILE7y9u8YuKoEgp4cPy","market":"us","size":5416},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925109698/acxp-20250930xex32d2.htm","primary":false,"translateUrl":"","linkName":"acxp-20250930xex32d2.htm","type":"EX-32.2","id":"NTFILE3x9CiUpbYZiJxEXL","market":"us","size":5454}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-11-12 13:00","pubTimestamp":1762923600,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20281987","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925100800-ACXP","pdf_url":"","pub_time":1760990512000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"ACXP","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1736243/0001104659-25-100800-index.html","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925100800/tm2528937d1_s1.htm","primary":true,"translateUrl":"","linkName":"tm2528937d1_s1.htm","type":"S-1","id":"NTFILE7vRC2oRjGUicX3Na","market":"us","size":399614},{"description":"EXHIBIT 5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925100800/tm2528937d1_ex5-1.htm","primary":false,"translateUrl":"","linkName":"tm2528937d1_ex5-1.htm","type":"EX-5.1","id":"NTFILEEJVHtBtLCsZQkkH7","market":"us","size":8969},{"description":"EXHIBIT 23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925100800/tm2528937d1_ex23-1.htm","primary":false,"translateUrl":"","linkName":"tm2528937d1_ex23-1.htm","type":"EX-23.1","id":"NTFILEHMvgPfgFjD2G91VD","market":"us","size":2519},{"description":"EX-FILING FEES","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925100800/tm2528937d1_ex-filingfees.htm","primary":false,"translateUrl":"","linkName":"tm2528937d1_ex-filingfees.htm","type":"EX-FILING FEES","id":"NTFILE4EupYw1589UmNCr3","market":"us","size":25788},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925100800/tm2528937d1_ex5-1img001.jpg","primary":false,"translateUrl":"","linkName":"tm2528937d1_ex5-1img001.jpg","type":"GRAPHIC","id":"NTFILE3qdW9w4PJyoQNSTX","market":"us","size":2705}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2025-10-21 04:01","pubTimestamp":1760990512,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20194064","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925092166-ACXP","pdf_url":"","pub_time":1758513600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ACXP","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925092166/0001104659-25-092166-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 3.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925092166/tm2526666d1_ex3-1.htm","primary":true,"translateUrl":"","linkName":"tm2526666d1_ex3-1.htm","type":"EX-3.1","id":"NTFILEBq5i9BKjgXtbhEwx","market":"us","size":7814},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925092166/tm2526666d1_8k.htm","primary":false,"translateUrl":"","linkName":"tm2526666d1_8k.htm","type":"8-K","id":"NTFILEA3Qbo4nYCCyMBLc8","market":"us","size":26750}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-09-22 12:00","pubTimestamp":1758513600,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.03项：公司章程或章程的修订；财政年度的变化；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20189198","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925091733-ACXP","pdf_url":"","pub_time":1758254400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ACXP","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925091733/0001104659-25-091733-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925091733/tm2526531d1_8k.htm","primary":true,"translateUrl":"","linkName":"tm2526531d1_8k.htm","type":"8-K","id":"NTFILEFrkAWToGZQKYzAan","market":"us","size":30709}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-09-19 12:00","pubTimestamp":1758254400,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"项目5.07：将事项提交证券持有人表决","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19972296","market":"us","labels":[],"media":"sec.gov","original_id":"AN155837025011045-ACXP","pdf_url":"","pub_time":1754884800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"ACXP","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1736243/000155837025011045/0001558370-25-011045-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000155837025011045/acxp-20250630x10q.htm","primary":true,"translateUrl":"","linkName":"acxp-20250630x10q.htm","type":"10-Q","id":"NTFILEGqa95PNFJjrL8kjg","market":"us","size":1609515},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000155837025011045/acxp-20250630xex31d1.htm","primary":false,"translateUrl":"","linkName":"acxp-20250630xex31d1.htm","type":"EX-31.1","id":"NTFILEDWnZNqQ1oNRUtxED","market":"us","size":12537},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000155837025011045/acxp-20250630xex31d2.htm","primary":false,"translateUrl":"","linkName":"acxp-20250630xex31d2.htm","type":"EX-31.2","id":"NTFILE9QRH25JxGnrS4Lhc","market":"us","size":12586},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000155837025011045/acxp-20250630xex32d1.htm","primary":false,"translateUrl":"","linkName":"acxp-20250630xex32d1.htm","type":"EX-32.1","id":"NTFILEEyTfoZyb1wvkpmLr","market":"us","size":5409},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000155837025011045/acxp-20250630xex32d2.htm","primary":false,"translateUrl":"","linkName":"acxp-20250630xex32d2.htm","type":"EX-32.2","id":"NTFILEHH3yve9nsXqqy4RH","market":"us","size":5447}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-08-11 12:00","pubTimestamp":1754884800,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19932007","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925072529-ACXP","pdf_url":"","pub_time":1753934400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ACXP","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925072529/0001104659-25-072529-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.03: Material Modifications to Rights of Security Holders;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 3.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925072529/tm2521773d1_ex3-1.htm","primary":true,"translateUrl":"","linkName":"tm2521773d1_ex3-1.htm","type":"EX-3.1","id":"NTFILECMJjbEdwCfUzSDcj","market":"us","size":7008},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925072529/tm2521773d1_8k.htm","primary":false,"translateUrl":"","linkName":"tm2521773d1_8k.htm","type":"8-K","id":"NTFILECnBFk9RBc2D3i8xv","market":"us","size":31972},{"description":"EXHIBIT 99.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925072529/tm2521773d1_ex99-1.htm","primary":false,"translateUrl":"","linkName":"tm2521773d1_ex99-1.htm","type":"EX-99.1","id":"NTFILE65Jpt57Kqh4ybk51","market":"us","size":11001}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-31 12:00","pubTimestamp":1753934400,"title_zh":"Form 8-K - Current report","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20016886","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925069322-ACXP","pdf_url":"","pub_time":1753129285000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"ACXP","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1736243/0001104659-25-069322-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925069322/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE9oCdKT1TXs56WfMC","market":"us","size":6924}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-07-22 04:21","pubTimestamp":1753129285,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19888381","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925068659-ACXP","pdf_url":"","pub_time":1752724800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ACXP","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925068659/0001104659-25-068659-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925068659/tm2521097d1_8k.htm","primary":true,"translateUrl":"","linkName":"tm2521097d1_8k.htm","type":"8-K","id":"NTFILEHkp52GAs52GBw5Ky","market":"us","size":39645}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-17 12:00","pubTimestamp":1752724800,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"项目5.07：将事项提交证券持有人表决","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19881828","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925067841-ACXP","pdf_url":"","pub_time":1752538965000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"ACXP","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1736243/0001104659-25-067841-index.html","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925067841/tm2520539d1_s1.htm","primary":true,"translateUrl":"","linkName":"tm2520539d1_s1.htm","type":"S-1","id":"NTFILEEXbkNScXcNumqkja","market":"us","size":318196},{"description":"EXHIBIT 5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925067841/tm2520539d1_ex5-1.htm","primary":false,"translateUrl":"","linkName":"tm2520539d1_ex5-1.htm","type":"EX-5.1","id":"NTFILECYzsrY8FgddZCrTp","market":"us","size":8882},{"description":"EXHIBIT 23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925067841/tm2520539d1_ex23-1.htm","primary":false,"translateUrl":"","linkName":"tm2520539d1_ex23-1.htm","type":"EX-23.1","id":"NTFILE5jmhs3cnvwatchn6","market":"us","size":2612},{"description":"EX-FILING FEES","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925067841/tm2520539d1_ex-filingfees.htm","primary":false,"translateUrl":"","linkName":"tm2520539d1_ex-filingfees.htm","type":"EX-FILING FEES","id":"NTFILE3jYGTZ6yFPoD8p7c","market":"us","size":9893},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925067841/tm2520539d1_ex5-1img001.jpg","primary":false,"translateUrl":"","linkName":"tm2520539d1_ex5-1img001.jpg","type":"GRAPHIC","id":"NTFILEF1GBicWdnCTMAX6R","market":"us","size":2705}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2025-07-15 08:22","pubTimestamp":1752538965,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19792165","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925060902-ACXP","pdf_url":"","pub_time":1750392000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ACXP","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/0001104659-25-060902-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 4.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/tm2518285d1_ex4-1.htm","primary":true,"translateUrl":"","linkName":"tm2518285d1_ex4-1.htm","type":"EX-4.1","id":"NTFILE5Kuf5LKuVNEzD2L1","market":"us","size":87719},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/tm2518285d1_8k.htm","primary":false,"translateUrl":"","linkName":"tm2518285d1_8k.htm","type":"8-K","id":"NTFILE9PK7H4pyQPL6phcX","market":"us","size":43898},{"description":"EXHIBIT 4.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/tm2518285d1_ex4-2.htm","primary":false,"translateUrl":"","linkName":"tm2518285d1_ex4-2.htm","type":"EX-4.2","id":"NTFILE2CQcHTv3hys7WNNz","market":"us","size":86716},{"description":"EXHIBIT 4.3","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/tm2518285d1_ex4-3.htm","primary":false,"translateUrl":"","linkName":"tm2518285d1_ex4-3.htm","type":"EX-4.3","id":"NTFILE8j99mA5EYdtkizsE","market":"us","size":90115},{"description":"EXHIBIT 10.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/tm2518285d1_ex10-1.htm","primary":false,"translateUrl":"","linkName":"tm2518285d1_ex10-1.htm","type":"EX-10.1","id":"NTFILEFu4wzXxRMypa5XvM","market":"us","size":70677},{"description":"EXHIBIT 99.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/tm2518285d1_ex99-1.htm","primary":false,"translateUrl":"","linkName":"tm2518285d1_ex99-1.htm","type":"EX-99.1","id":"NTFILE2b7ijiZdjY6EDyZa","market":"us","size":13547}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-06-20 12:00","pubTimestamp":1750392000,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19835472","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925052966-ACXP","pdf_url":"","pub_time":1748376370000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"ACXP","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1736243/0001104659-25-052966-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925052966/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE5MXb8tsu8UM8btJz","market":"us","size":7827}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-05-28 04:06","pubTimestamp":1748376370,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.acurxpharma.com","stockEarnings":[{"period":"1week","weight":1.4604},{"period":"1month","weight":1.4416},{"period":"3month","weight":0.3398},{"period":"6month","weight":0.1675},{"period":"1year","weight":-0.4783},{"period":"ytd","weight":0.9317}],"compareEarnings":[{"period":"1week","weight":-0.0136},{"period":"1month","weight":-0.0187},{"period":"3month","weight":-0.0145},{"period":"6month","weight":0.0149},{"period":"1year","weight":0.1887},{"period":"ytd","weight":-0.0189}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acurx Pharmaceuticals, Inc.于2017年7月在特拉华州注册成立，于2018年2月开始运营。该公司是一家后期生物制药公司，专注于开发用于难治疗细菌感染的新型小分子抗生素，用于治疗被世界卫生组织列为优先病原体的细菌引起的感染（“WHO”），美国疾病控制与预防中心（“CDC”）和美国食品和药物管理局（“FDA”）。优先病原体是那些需要新抗生素来解决由WHO、CDC和FDA确定的全球抗微生物药物耐药性（“AMR”）危机的病原体。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.08634},{"month":2,"riseRate":0,"avgChangeRate":-0.144545},{"month":3,"riseRate":0.4,"avgChangeRate":0.31133},{"month":4,"riseRate":0.5,"avgChangeRate":0.00047},{"month":5,"riseRate":0.5,"avgChangeRate":-0.04935},{"month":6,"riseRate":0.5,"avgChangeRate":0.118659},{"month":7,"riseRate":0,"avgChangeRate":-0.160175},{"month":8,"riseRate":0.2,"avgChangeRate":-0.087422},{"month":9,"riseRate":0,"avgChangeRate":-0.115354},{"month":10,"riseRate":0.6,"avgChangeRate":0.545147},{"month":11,"riseRate":0.2,"avgChangeRate":-0.181708},{"month":12,"riseRate":0.4,"avgChangeRate":-0.094208}],"exchange":"NASDAQ","name":"Acurx Pharmaceuticals, LLC*","nameEN":"Acurx Pharmaceuticals, LLC*"},"aProfile":null}}}